|Last Price||Today's Change||52-Week Range||Trading Volume|
|418.72||5.68 (+1.38%)||269.50 - 437.64||46.3 thousand (Above Avg)|
Market data as of 9:37AM 03/05/15. Quotes are delayed by at least 15 min.
NIH-Sponsored Comparative Effectiveness Trial in Diabetic Macular Edema Shows EYLEA® (aflibercept) Injection Demonstrated Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab
02/18/2015 5:00 PM ET